Home / Research Library / Chronic kidney disease
🧬 Medicine & Biology OpenAlex

Chronic kidney disease

📅 June 24, 2021 👤 Kamyar Kalantar‐Zadeh, Tazeen H. Jafar, Dorothea Nitsch et al. 📖 The Lancet 📊 1,388 citations

🤖 Plain-English Summary

Chronic kidney disease is a progressive disease with no cure and high morbidity and mortality that occurs commonly in the general adult population, especially in people with diabetes and hypertension. There are similarities and distinctions between kidney-preserving care and supportive care.

🔑 Key Findings

  • Preservation of kidney function can improve outcomes and can be achieved through non-pharmacological strategies (eg, dietary and lifestyle adjustments) and chronic kidney disease-targeted and kidney disease-specific pharmacological interventions.
  • A plant-dominant, low-protein, and low-salt diet might help to mitigate glomerular hyperfiltration and preserve renal function for longer, possibly while also leading to favourable alterations in acid-base homoeostasis and in the gut microbiome.
  • Pharmacotherapies that alter intrarenal haemodynamics (eg, renin-angiotensin-aldosterone pathway modulators and SGLT2 [SLC5A2] inhibitors) can preserve kidney function by reducing intraglomerular pressure independently of blood pressure and glucose control, whereas other novel agents (eg, non-steroidal mineralocorticoid receptor antagonists) might protect the kidney through anti-inflammatory or antifibrotic mechanisms.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Jun 24, 2021
Journal The Lancet
Authors Kamyar Kalantar‐Zadeh, Tazeen H. Jafar, Dorothea Nitsch, Brendon L. Neuen, Vlado Perkovic
DOI 10.1016/s0140-6736(21)00519-5
Citations 1,388
Source OpenAlex

More 🧬 Medicine & Biology Research